7.72

0.39% -0.03

After Hours: 7.72

Optimizerx Corp (OPRX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Optimizerx Corp stock is traded at $7.72, with a volume of 50,026. It is down -0.39% in the last 24 hours and down -7.10% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Previous Close:

$7.75

Open:

$7.61

24h Volume:

50,026

Relative Volume:

0.44

Market Cap:

$140.35M

Revenue:

$62.81M

Net Income/Loss:

$-13.75M

P/E Ratio:

-9.4146

EPS:

-0.82

Net Cash Flow:

$153.00K

1W Performance:

-5.39%

1M Performance:

-7.10%

6M Performance:

-36.46%

1Y Performance:

-0.77%

1-Day Range:

$7.605

$7.8414

1-Week Range:

$7.27

$8.20

52-Week Range:

$6.92

$16.64

Optimizerx Corp Stock (OPRX) Company Profile

Name

Optimizerx Corp

Sector

Healthcare (1190)

Industry

Health Information Services (64)

Phone

248-651-6558

Address

260 CHARLES STREET, WALTHAM, MI

Employee

136

Twitter

@OpRxTweets

Next Earnings Date

2024-08-08

Latest SEC Filings

OPRX's Discussions on Twitter

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-02-23	Resumed	B. Riley Securities	Buy
Nov-01-22	Initiated	Stifel	Buy
Jul-15-22	Initiated	SVB Leerink	Outperform
Oct-18-21	Resumed	B. Riley Securities	Buy
Apr-13-21	Initiated	RBC Capital Mkts	Outperform
Jan-03-19	Initiated	William Blair	Outperform

View All

Optimizerx Corp Stock (OPRX) Latest News

Sep 28, 2024

Rhumbline Advisers Increases Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Sep 28, 2024

Sep 21, 2024

OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of New York Mellon Corp - Defense World

Sep 21, 2024

Sep 20, 2024

Divisadero Street Capital Management LP Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Sep 20, 2024

Sep 11, 2024

OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat

Sep 11, 2024

Sep 10, 2024

OptimizeRx expands pharma client engagement to $10M - Investing.com

Sep 10, 2024

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - The Tech Outlook

Sep 10, 2024

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a - The Bakersfield Californian

Sep 10, 2024

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - StockTitan

Sep 10, 2024

OptimizeRx Launches Novel Brand Eligibility Technology - Martechcube

Sep 10, 2024

OptimizeRx expands pharma client engagement to $10M - Investing.com India

Sep 10, 2024

Sep 09, 2024

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - ForexTV.com

Sep 09, 2024

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - StockTitan

Sep 09, 2024

Sep 04, 2024

Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround - Yahoo Finance

Sep 04, 2024

Aug 18, 2024

OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00 - Defense World

Aug 18, 2024

Aug 14, 2024

Vanguard Group Inc. Raises Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Aug 14, 2024

Aug 12, 2024

OptimizeRx (NASDAQ:OPRX) PT Lowered to $11.00 - Defense World

Aug 12, 2024

A Closer Look at 5 Analyst Recommendations For OptimizeRx - Benzinga

Aug 12, 2024

Aug 11, 2024

Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 - Yahoo Finance

Aug 11, 2024

Aug 10, 2024

OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK

Aug 10, 2024

Contrasting OptimizeRx (NASDAQ:OPRX) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) - Defense World

Aug 10, 2024

Aug 09, 2024

Earnings call: OptimizeRx reports solid growth, misses revenue target - Investing.com

Aug 09, 2024

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 09, 2024

Aug 08, 2024

Institutional investors may adopt severe steps after OptimizeRx Corporation's (NASDAQ:OPRX) latest 24% drop adds to a year losses - Yahoo Finance

Aug 08, 2024

Aug 01, 2024

Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates - Zacks Investment Research

Aug 01, 2024

OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat

Aug 01, 2024